Search results
CAR T-Cell Therapies Under FDA Watch on Reports of Malignancies
Zacks via Yahoo Finance· 5 months agoThe FDA has undertaken an investigation of T-cell malignancies in patients undergoing CAR T-cell...
Kite's Tecartus CAR T-Cell Therapy Demonstrates Durable Overall Survival Benefit In Leukemia...
Benzinga via Yahoo Finance· 1 year agoKite, a Gilead Sciences Inc (NASDAQ: GILD) company, announced the three-year follow-up results from...
FDA warns of secondary cancer risk tied to CAR-T therapies that treat cancer
CNN via Yahoo News· 3 months agoThe US Food and Drug Administration has issued a new warning about the possible risk of secondary...
Gilead (GILD) Kite Reports Positive Data on CAR T-Cell Therapy
Zacks via Yahoo Finance· 1 year agoGilead Sciences’ GILD Kite announced encouraging three-year follow-up results from the ZUMA-3 study...
Eyes On Novartis, Gilead, Bristol Myers As FDA Weighs Risks Vs. Benefits Of Approved CAR T-Cell...
Benzinga via Yahoo Finance· 5 months agoTuesday, the FDA said it received reports of patients developing T-cell malignancies, including...
FDA says cancer treatment CAR-T therapy may increase risk of cancer
NBC News via Yahoo News· 3 months agoThe Food and Drug Administration this week told several drugmakers to add a boxed warning — the...
FDA orders new cancer warnings for CAR-T therapies
BioPharma Dive via Yahoo Finance· 3 months agoThe agency later modified its warning for Gilead's Tecartus, tweaking the label's language to reflect the fact that none of T cell malignancies in...
Kite Pharma's CAR T-Cell Therapy Wins European Approval In Refractory Leukemia Setting
Benzinga via Yahoo Finance· 2 years agoThe European Commission has approved Gilead Science Inc (NASDAQ: GILD) company Kite Pharma's CAR...
Gilead CAR-T cancer therapy capacity to quadruple by 2026
Reuters via Yahoo News· 1 month agoGilead Sciences will be able to quadruple production of its cell therapy cancer treatments by 2026...
US FDA seeks 'boxed warning' for CAR-T cancer therapies
Reuters via Yahoo News· 3 months ago(Reuters) -The U.S. health regulator on Monday asked a host of drugmakers, including Gilead...